Max Healthcare

What Max Healthcare does

Max Healthcare Institute Limited (NSE: MAXHEALTH) is one of India's largest publicly listed hospital operators, headquartered in New Delhi and operating a network of 21 owned multi-speciality and super-speciality hospitals with over 6,000 beds across Delhi NCR, Punjab, Uttarakhand, Uttar Pradesh, Maharashtra, and Odisha. Approximately 73–85% of bed capacity is concentrated in Metro and Tier-1 cities, where it offers tertiary and quaternary care across 35+ specialties including oncology, cardiac sciences, neurosciences, orthopaedics, organ transplantation, nephrology, and robotic surgery. The clinical platform is built around advanced medical technologies — Da Vinci Xi robotic surgical systems, Mako robotic-arm assisted joint replacement, TrueBeam linear accelerator with Exactrac for SBRT, intraoperative CT navigation, and CUSA for neurosurgical/oncological procedures — supported by over 5,800 doctors and named Group Chairmen in each major specialty. Two wholly-owned adjacencies — Max Lab (pathology and diagnostics) and Max@Home (home healthcare services) — extend the care continuum outside hospital walls, while Max Research Centre and MIME drive clinical trials and academic programming.

The company generates revenue primarily through inpatient and outpatient hospital services (bed occupancy, ARPOB, procedure volumes), supplemented by international patient revenue from medical tourists across approximately 145 countries (facilitated by 23 overseas offices and growing ~25% annually), Max Lab diagnostics, Max@Home services, and government health scheme empanelment (CGHS/ECHS). Q4 FY26 gross revenue was Rs 2,664 crore (+10% YoY), full-year FY26 gross revenue reached Rs 10,538 crore (+16% YoY), and network PAT grew 22% to Rs 1,631 crore, marking the 22nd consecutive quarter of YoY growth. The business model is asset-intensive and self-funded: FY26 free cash from operations of Rs 581 crore and net debt/EBITDA below 1x support an announced Rs 6,000 crore capex program targeting 10,000+ beds by FY30, supplemented by recent acquisitions (Alexis Hospital Nagpur 2024, Jaypee Healthcare 2024, Kalinga Hospital 2026) and a greenfield 712-bed Lucknow hospital approved in May 2026.

Name

Max Healthcare

Legal name

Max Healthcare Institute Limited

Website

https://maxhealthcare.in

Company type

Public

Founded year

2000

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Max Healthcare Institute Limited (NSE: MAXHEALTH) operates 21 owned multi-speciality hospitals with 6,000+ beds across India, delivering tertiary and quaternary care — including robotic surgery, organ transplants, oncology and cardiac sciences — to metro and Tier-1 domestic patients and international medical tourists from 145 countries, alongside Max Lab diagnostics and Max@Home services.

Ownership category

akta.pro rank

Product category

Multi-Specialty Hospital Services

NAICS

General Medical and Surgical Hospitals (622110)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industry

Hospital-at-Home / Acute Care at Home Programs (HLAFAEAH)

Keywords

• Multi-specialty hospital services
• Tertiary and quaternary care
• Robotic surgery services
• Organ transplantation
• Home healthcare services

Headquarters

HQ city

Ghaziabad

HQ country

India

HQ region

Asia

Offices18 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Hospital Healthcare Services: Max Healthcare generates the majority of its revenue through inpatient and outpatient hospital services including consultations, procedures, surgeries, diagnostics, and hospital stays. Revenue is driven by bed occupancy, ARPOB (average revenue per occupied bed), and volume of procedures across its network of 21 hospitals. The company also earns from diagnostics (Max Lab) and home healthcare (Max@Home).
2. Medical Tourism: International patients from approximately 145 countries contribute revenue through self-pay and insurance arrangements, with the company growing its overseas office footprint from 2 to 23 over four years to capture inbound medical tourism.
3. Diagnostic Services (Max Lab): Pathology and diagnostic services offered both within hospitals and externally through Max Lab standalone centers.
4. Home Healthcare (Max@Home): Health and wellness services delivered at patient homes, including nursing care, physiotherapy, diagnostic sample collection, and health checkup packages.

Pricing tiers

Go-to-market motion2 records

Distribution channels8 records

Marketing channels10 records

Core offering

Max Healthcare operates a network of 21 multi-specialty and super-specialty hospitals across India with over 6,000 beds, providing tertiary and quaternary clinical services including oncology, cardiac sciences, neurosciences, orthopaedics, organ transplantation (liver, kidney, bone marrow, heart, lung), robotic surgery (Da Vinci Xi, Mako), and advanced diagnostics. The company complements its inpatient and outpatient hospital services with two satellite lines: Max Lab (pathology and diagnostics) and Max@Home (home healthcare including nursing care, physiotherapy, diagnostic sample collection, and ambulance services), and supports an academic and research arm (Max Institute of Medical Education, Max Research Centre).

Product overview

Max Healthcare operates a network of 21 hospitals and healthcare facilities across India as a unified platform-plus-multiple-location model. The core offering consists of multi-speciality and super-speciality hospitals providing comprehensive inpatient and outpatient care across 35+ medical specialties including oncology, cardiac sciences, neurosciences, orthopaedics, nephrology, organ transplants, and robotic surgery. The hospital network spans Delhi NCR, Punjab, Uttarakhand, Maharashtra, Uttar Pradesh, and Odisha with over 6,000 beds, with 73% of capacity in metro cities. Adjacent to hospitals, Max Healthcare operates two satellite service modules: Max Lab (pathology and diagnostic services) and Max@Home (home healthcare and wellness services). The network also includes an academic arm (Max Institute of Medical Education) and a research centre (Max Research Centre) for clinical trials and academic collaborations. The company has pursued an aggressive expansion strategy through brownfield capacity additions at existing facilities (e.g., 400-bed Saket Smart Tower, Mohali upgrade) and acquisitions (Alexis Hospital/Nagpur, Jaypee Healthcare/Noida, Kalinga Hospital/Bhubaneswar), with plans to reach 10,000 beds over the next 3-4 years.

Differentiator

Problem solved

Functional benefit

Brands

• Max@Home: Home healthcare division offering health and wellness services at home
• Max Lab
• Max Research Centre

Products and services

• Max Smart Super Speciality Hospital, Saket Flagship multi-specialty hospital in Delhi's Saket area featuring 1,160+ beds across 35+ specialties, with advanced robotic surgery capabilities (Da Vinci Xi, Mako), critical care beds, modular operating theatres, and advanced Cath Labs. Serves as a primary referral center for complex tertiary and quaternary care.
• Max Super Speciality Hospital, Saket Multi-specialty hospital in Saket, Delhi offering comprehensive healthcare services across multiple specialties including oncology, cardiac sciences, neurology, and organ transplants. JCI and NABH accredited.
• BLK-Max Super Speciality Hospital, Delhi
• Nanavati-Max Super Speciality Hospital, Mumbai
• Max Super Speciality Hospital, Mohali
• Max Super Speciality Hospital, Lucknow Multi-specialty hospital in Lucknow, Uttar Pradesh offering advanced healthcare services with planned expansion including a new 712-bed greenfield facility.
• Max Super Speciality Hospital, Nagpur 200-bed multidisciplinary hospital in Nagpur, Maharashtra acquired from Alexis Multi Speciality Hospital and rebranded as Max Super Speciality Hospital. Offers advanced medical technology with potential for capacity expansion to 340 beds.
• Max Super Speciality Hospital, Sector-128, Noida 500-bed multi-specialty hospital in Noida acquired as part of Jaypee Healthcare stake acquisition, offering comprehensive healthcare services in the Delhi NCR region.
• Kalinga Hospital, Bhubaneswar 250-bed multi-specialty hospital in Bhubaneswar, Odisha acquired by Max Healthcare, marking the company's entry into eastern India with significant brownfield expansion potential.
• Max Lab
• Max@Home
• Robotic Surgery Services (Da Vinci Xi & Mako)
• Max Research Centre

Quantifiable outcome

• 22 consecutive quarters of year-on-year growth in network revenue
• +6 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

23 partnerships are on record, tiered core and minor.

• 4baseCarecoreStrategic or Co-development Partner · 11 June 2026Bengaluru-based precision oncology startup 4baseCare partnered with Max Healthcare among other hospitals (AIIMS Jammu, Shankara Hospital) to decentralize genomic testing infrastructure. 4baseCare operates labs in India, Dubai, Nepal, and the Philippines and is scaling its AI-powered oncology platform OncoTwin that creates digital twins of cancer patients.
• StrykercoreStrategic or Co-development Partner · 13 May 2026Stryker and Max Smart Super Speciality Hospital, Saket announced a strategic collaboration to establish the hospital as a training and education center for robotic-arm assisted joint replacement surgery in India. The partnership aims to address India's growing burden of arthritis and joint disorders by developing clinical expertise and improving access to technology-enabled treatment approaches through structured surgeon training frameworks.
• Imperial College LondoncoreStrategic or Co-development Partner · 1 January 2025International academic research collaboration focused on advancing healthcare research through joint studies, clinical trials, and academic exchanges in areas of mutual interest.
• Karolinska InstitutecoreStrategic or Co-development Partner · 1 January 2025Research collaboration with the renowned Swedish medical university for joint research initiatives and knowledge sharing in healthcare innovation.
• Monash UniversitycoreStrategic or Co-development Partner · 1 January 2025Academic partnership with Monash University for research collaborations, student exchanges, and joint academic programs in healthcare and medical sciences.
• Deakin UniversityminorStrategic or Co-development Partner · 1 January 2025Academic research collaboration with Deakin University focused on healthcare delivery research and medical education.
• BRAC UniversityminorStrategic or Co-development Partner · 1 January 2025Partnership with BRAC University for public health research collaborations and community healthcare initiatives.
• Aston UniversityminorStrategic or Co-development Partner · 1 January 2025Academic research partnership with Aston University for healthcare-related research and academic programs.
• IIT BombaycoreStrategic or Co-development Partner · 1 January 2025Research collaboration with IIT Bombay bringing expertise in data science, computational biology, and AI/ML for big data analytics and predictive modeling for diagnostic and prognostic benefits.
• IIT DelhicoreStrategic or Co-development Partner · 1 January 2025Research partnership with IIT Delhi for AI/ML applications in healthcare diagnostics, predictive modeling, and digital health solutions.
• BITS PilanicoreStrategic or Co-development Partner · 1 January 2025Collaboration with BITS Pilani for computational biology, AI/ML research, and digital health innovations.
• IIIT DelhicoreStrategic or Co-development Partner · 1 January 2025Partnership with IIIT Delhi for data science, AI/ML applications in healthcare, and predictive modeling for diagnostics.
• Ashoka UniversitycoreStrategic or Co-development Partner · 1 January 2025Collaboration with Ashoka University for research in oncology, antimicrobial resistance, and diabetes, including funded research grants and real-world evidence studies.
• Pfizer Inc.coreStrategic or Co-development Partner · 1 January 2025Strategic collaboration with Pfizer for real-world evidence studies, capacity building in infectious diseases and rheumatology, and clinical research programs.
• Regional Centre for Biotechnology (RCB)coreStrategic or Co-development Partner · 1 January 2025Partnership with RCB for MSc Clinical Research degree program and biotechnology research collaborations.
• Academy of Scientific and Innovative Research (AcSIR)coreStrategic or Co-development Partner · 1 January 2025Collaboration with AcSIR to offer degree programs including Master's in Public Health and PhD programs, making Max Healthcare the first private provider to offer such academic degree programs.
• Mazumdar Shaw Medical FoundationminorStrategic or Co-development Partner · 1 January 2025Research collaboration with Mazumdar Shaw Medical Foundation for cancer research and healthcare delivery studies.
• Madras Diabetes Research FoundationminorStrategic or Co-development Partner · 1 January 2025Partnership focused on diabetes research collaborations and metabolic disorder studies.
• Institute of Genomics & Integrative Biology (IGIB)minorStrategic or Co-development Partner · 1 January 2025Genomics and molecular biology research collaboration for precision medicine and genetic disorder studies.
• National Centre for Biological Science (NCBS)minorStrategic or Co-development Partner · 1 January 2025Research collaboration in biological sciences for advanced healthcare research and innovation.
• Tata Institute for Genetics and Society (TIGS)minorStrategic or Co-development Partner · 1 January 2025Genetics and genome research collaboration for advancing precision medicine initiatives.
• Rajiv Gandhi Centre for BiotechnologyminorStrategic or Co-development Partner · 1 January 2025Biotechnology research partnership for cancer genomics and molecular diagnostics.
• Gautam Buddha UniversityminorStrategic or Co-development Partner · 1 January 2025Academic collaboration for MSc in Nuclear Medicine program and other healthcare education initiatives in the Noida region.

Scale indicators14 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Apollo Hospitals Enterprise: Apollo Hospitals is India's largest hospital chain and the most direct comparable to Max Healthcare. It operates a similar network of multi-specialty and super-specialty tertiary/quaternary hospitals across India, competes head-to-head in Delhi NCR and Mumbai, and runs an established medical tourism and diagnostics (Apollo Diagnostics) franchise.
• Fortis Healthcare: Fortis Healthcare operates a comparable multi-specialty hospital network across India, with material overlap in Delhi NCR, Punjab, and other regions where Max Healthcare is present. It competes on tertiary care, cardiac sciences, oncology, and orthopedics, and was a co-respondent with Max in CCI pricing investigations.
• Medanta (Global Health): Medanta is a leading multi-super-specialty hospital chain founded by Dr. Naresh Trehan with strong presence in Delhi NCR, Lucknow, Patna, Indore and other cities. It directly competes with Max in tertiary cardiac, oncology, and organ transplant services, and pursues a similar metro-Tier 2 expansion strategy.
• Manipal Hospitals: Manipal Hospitals operates one of India's largest multi-specialty hospital networks, with a pan-India footprint acquired via the Columbia Asia integration. It competes with Max in tertiary and quaternary care, has comparable technology investments in robotic surgery, and pursues aggressive expansion through acquisitions.
• Narayana Health: Narayana Health is a multi-specialty hospital chain with notable strength in cardiac sciences, oncology, and renal sciences — areas where Max Healthcare has strong franchises. It operates facilities across India and competes for both domestic and international patients in several specialties.
• Aster DM Healthcare: Aster DM Healthcare operates hospitals and clinics across India and the GCC, with comparable multi-specialty offerings and an international patient focus. It competes with Max Healthcare in tertiary care delivery and shares the medical tourism angle, particularly through its India operations.
• Healthcare Global Enterprises (HCG): HCG is India's largest oncology-focused hospital chain. While narrower in specialty than Max Healthcare, it is a direct comparable within Max's cancer care franchise and competes for medical tourism patients seeking advanced oncology treatment, including precision oncology and CAR T-cell therapy.
• Artemis Hospital: Artemis Hospital is a multi-super-specialty hospital in Gurugram directly competing with Max's Gurgaon facility on tertiary care, cardiac sciences, oncology, and orthopedics. It is JCI and NABH accredited and serves a similar HNI and medical tourism demographic.
• KIMS Hospitals: KIMS Hospitals operates a multi-specialty hospital network primarily in South India with expansion into other regions. It is comparable as a publicly listed, acquisition-active hospital chain pursuing pan-India growth with a similar focus on tertiary and quaternary care.
• Shalby Hospitals: Shalby Hospitals is a multi-specialty hospital chain with particular strength in orthopedics and joint replacement, areas where Max Healthcare has invested heavily in robotic surgery (Mako). It competes for similar tertiary care patient pools across several Indian cities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/MaxHealthcare
• YouTubeyoutube.com/user/maxhcvideos
• Facebookfacebook.com/MaxHospitalsIndia
• LinkedInlinkedin.com/company/max-healthcare
• Instagraminstagram.com/max.healthcare/?hl=en

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries6 records

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Max Healthcare